Errors and Omissions Disclaimer: Every effort has been made to ensure the accuracy and reliability of the information presented
Drugdrug interactions also represent a significant concern, especially when new XO inhibitors are metabolized by similar enzymatic pathways as other therapeutics, potentially leading to adverse interactions or altered pharmacodynamics
For this axis, relevant endpoints include phosphorylation of anabolic signaling intermediates, expression of muscle-regulatory genes, satellite cell activity, and indices of protein accretion or repair
No real-time collaboration : Sharing works but no simultaneous editing or live cursors
Nakanishi H, Kurosaki M, Tsuchiya K, et al
Good review: To view or add a comment, sign in More Relevant Posts As we weigh the risks and benefits of trialing JAK inhibitors for our patients with chronic skin conditions, a periodic review of the literature regarding this class of medication's safety profile is beneficial
